Results 111 to 120 of about 4,498 (182)

Pharmacokinetics, safety and efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in children with HIV aged from 2 years and weighing at least 14 kg. [PDF]

J Int AIDS Soc
Natukunda E, Gaur AH, Kosalaraksa P, Hellström E, Strehlau R, Liberty A, Cox S, Leisegang R, Palaparthy R, Crowe S, Vieira V, Kersey K, Rakhmanina N.   +12 more
europepmc   +1 more source

2025 US Public Health Service Guidelines for the Management of Occupational Exposures to Human Immunodeficiency Virus and Recommendations for Post-exposure Prophylaxis in Healthcare Settings. [PDF]

Infect Control Hosp Epidemiol
Kofman AD, Struble KA, Heneine W, Gayle B, de Perio MA, Okasako-Schmucker DL, So CN, Anderson LE, Stone EC, Henderson DK, Kuhar DT.   +10 more
europepmc   +1 more source

Orthostatic hypotension in a patient with HIV: uncovering adrenal insufficiency from fluticasone-cobicistat interactions. [PDF]

CMAJ
Dienes S, Nunn R, Lai A.
europepmc   +1 more source

Immediate and delayed switches to tenofovir DF-containing, ainuovirine-based antiretroviral regimen: the SPRINT extensional study. [PDF]

BMC Med
Zhang F, Cai W, Wu H, Ma P, Zhao Q, Wei H, Lu H, Wang H, He S, Chen Z, Chen Y, Wang M, Yun X, Zhou Z, Fu H, Qin H.   +15 more
europepmc   +1 more source

Contemporary Antiretroviral Therapy Regimens in People With HIV Who Initiated Treatment in the Pre-Antiretroviral Therapy Era. [PDF]

J Med Virol
Adachi E, Okuno S, Kanno Y, Koga M, Yotsuyanagi H.   +4 more
europepmc   +1 more source

DEFINE: A Prospective, Randomized, Phase 4 Trial to Assess a Protease Inhibitor-Based Regimen Switch Strategy to Manage Integrase Inhibitor-Related Weight Gain. [PDF]

Clin Infect Dis
Anderson D, Ramgopal M, Hagins DP, Lee J, Simonson RB, Hsu TH, Xu P, Ahmad N, Short WR.   +8 more
europepmc   +1 more source

Preswitch Regimens Associated With Weight Gain Among Persons With HIV who Switch to Integrase Inhibitor-Containing Regimens. [PDF]

Open Forum Infect Dis
Cutshaw MK, Harding M, Davenport CA, Okeke NL.   +3 more
europepmc   +1 more source